Data / Drug companies / Calcium-sensing Receptor Agonist
Calcium-sensing Receptor Agonist drugs: 3 drugs from 19 companies in the FDA NDC directory
Calcium-sensing Receptor Agonist is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 54 products in this class from 19 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on April 23, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 19Companies
- 54Products
- 3Drugs by generic name
Drugs in the Calcium-sensing Receptor Agonist class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Cinacalcet | 48 | 18 |
| Cinacalcet hydrochloride | 3 | 1 |
| Etelcalcetide | 3 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amgen, Inc | 6 | tablet, coated; injection, solution | New drug applications (NDA) | April 3, 2017 |
| Bryant Ranch Prepack | 5 | tablet, film coated | Generic drugs (ANDA) | May 18, 2019 |
| Bryant Ranch Prepack | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | May 18, 2019 |
| Accord Healthcare Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | June 16, 2020 |
| Amneal Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | December 6, 2021 |
| Ascend Laboratories, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | May 18, 2019 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | March 23, 2026 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | March 8, 2018 |
| Camber Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 7, 2020 |
| Cipla USA Inc. | 3 | tablet | Generic drugs (ANDA) | March 8, 2018 |
| Exelan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | April 14, 2020 |
| Strides Pharma Science Limited | 3 | tablet, film coated | Generic drugs (ANDA) | August 22, 2019 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 15, 2019 |
| XLCare Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 16, 2021 |
| Dr. Reddy's Laboratories Inc. | 2 | tablet | Generic drugs (ANDA) | September 18, 2020 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | June 10, 2025 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | March 16, 2026 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | January 29, 2025 |
| Remedyrepack Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | April 23, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 33 | 61.1% |
| Tablet | 15 | 27.8% |
| Tablet, coated | 3 | 5.6% |
| Injection, solution | 3 | 5.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.